Bio-Rad manufactures and markets products and systems to the life science research, healthcare, and analytical chemistry markets. The company majorly operates through two business segments, namely, Life Sciences and Clinical Diagnostics. The Clinical Diagnostics segment develops, manufactures, sells, and supports a large portfolio of products for medical screening and diagnostics. The life sciences segment develops, manufactures, and markets more than 5,000 reagents, apparatus, and laboratory instruments, globally. Under this segment, the company markets a number of reagents and antibodies required in research techniques, biopharmaceutical production processes, and food testing regimes. The company serves life science research and clinical diagnostics customers worldwide through a global network of operations.